Founders’ story: NeuroFlow

Why did you start this company?

My co-founder, Chris Molaro, and I met while studying at the University of Pennsylvania. He was pursuing his MBA and I was in the bioengineering PhD program. We connected over a shared passion for utilizing technology to solve high impact problems and it quickly became apparent that we had the chemistry to build something special together. The unmet need in the healthcare industry, coupled with the rapidly growing sophistication of software, created a unique opportunity for us to build a technology company that could finally help bridge the gap between mental and physical health.

What specific need/problem are you seeking to address in healthcare?

There are several flaws with the way healthcare infrastructure has traditionally been set up to treat patients. First, it was constructed in a world where patients are quickly cycled through in-person appointments that focus on physical health and rarely touch on emotional well-being, despite its massive effect on overall health. It’s time to replace this outdated model with a more integrated, collaborative approach to increase access to care, improve patient outcomes, and reduce the total cost of care.

What does your product do? How does it work?

Philosophically, it brings together measurement-based care and artificial intelligence to inform providers and support patients at the right level of care. The technology itself includes an award-winning patient facing mobile application for individuals to manage and measure their overall wellness. End user activity and engagement from the app is consolidated and shared with care teams and providers through our clinical decision support tool so they can perform measurement based care and leverage applied AI to perform risk stratification and deliver integrated care to those that need it the most.

Is this your first healthcare startup? What’s your background in healthcare?

Previously, I worked in sales for another high growth analytics company based in Philadelphia —Sidecar. It was while studying at the University of Pennsylvania, under Dr. Louis Soslowsky in the McKay Orthopaedic Laboratory, that I was exposed to the clinical treatment of tendon and other physical injuries. I absorbed some of these practical skills and began to take a serious interest in mental health care and behavioral science, after meeting my co-founder. Not unlike many people in healthcare, my father is also a radiologist so medicine has been a part of my life for a long time.

What is your company’s business model?

We are a software-as-a-service company that offers subscriptions to health systems, health plans, and other organizations across the continuum of care. We’ve developed a comprehensive suite of highly dynamic applications that can be largely customized depending on the setting.

Who is your customer? How do you generate revenue?

We currently support hundreds of organizations ranging from small, private practices up to major health systems, health insurers, as well as military and government organizations to meet the growing demand for mental health in all care settings. We leverage a SaaS subscription model for our technology.

Do you have clinical validation for your product?

Our technology makes it easier for providers and health systems to adopt an integrated, measured approach that is proven to improve outcomes and reduce the cost of care. NeuroFlow’s tools leverage evidence-based treatments to support patient care remotely.

Beyond the dozens of papers and studies highlighting the benefits of collaborative care and evidence-based interventions, our own internal data showcases how remote monitoring can improve engagement and outcomes. Not only do 76% of users on NeuroFlow stay engaged past six weeks, they complete an average of 31 activities in their first month. More importantly, 78% of all users report improvement in depression symptoms, according to validated rating scales, since starting to use NeuroFlow.

Featured Photo: Andrzej Wojcicki, Getty Images